Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP605454.RARj_iiAqJWOLO0pFUlsaCTjSDFp7LOnVV6_qPqaqZY3k130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605454.RARj_iiAqJWOLO0pFUlsaCTjSDFp7LOnVV6_qPqaqZY3k130_provenance.
• NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_provenance.
• NP370839.RALWlbj503SpJuWZ_xSyXA23W_lwbFYJds3HjUP3l3PRo130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370839.RALWlbj503SpJuWZ_xSyXA23W_lwbFYJds3HjUP3l3PRo130_provenance.
• NP879723.RAxbGn6BRCR5MhIfXKHhGjhumYHchh8TJSPpehpBKcXas130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879723.RAxbGn6BRCR5MhIfXKHhGjhumYHchh8TJSPpehpBKcXas130_provenance.
• NP618701.RAUYQp_n5vF1UP7tUfPVLRXKhF5c2vxHrnTwlXpyGxtgQ130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618701.RAUYQp_n5vF1UP7tUfPVLRXKhF5c2vxHrnTwlXpyGxtgQ130_provenance.
• assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1012565.RADUcPwi7wIIcIqTaWrHXmETJROMcS2ygK5jnLzFlRm50130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012565.RADUcPwi7wIIcIqTaWrHXmETJROMcS2ygK5jnLzFlRm50130_provenance.
• NP318264.RAmpk2tOSVXWyH_ig7peDTvhTpJhi0q-7gOutLVpjgZxk130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318264.RAmpk2tOSVXWyH_ig7peDTvhTpJhi0q-7gOutLVpjgZxk130_provenance.
• NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932500.RAuSnvF002DI05gdMj3uI5E2svYvJqmcAk0aeYu-A6Vdc130_provenance.
• NP452571.RAeYe1euX76HcWlipJMqysCqGLA4z_todFi3cX5fwDuMw130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452571.RAeYe1euX76HcWlipJMqysCqGLA4z_todFi3cX5fwDuMw130_provenance.
• NP452580.RAQL7xkMA7arOQELU3INzpXDHDJuzPisbkJdC9v3xIE3Y130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452580.RAQL7xkMA7arOQELU3INzpXDHDJuzPisbkJdC9v3xIE3Y130_provenance.
• NP1012539.RAq8NtFkH6dm2e3t8nKgcZ39yKSjIpf5XhD0LedqLRI98130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012539.RAq8NtFkH6dm2e3t8nKgcZ39yKSjIpf5XhD0LedqLRI98130_provenance.
• NP452572.RAn1M-PmcmEXGAyStV5E4gWs-zoGNZq0SHHpf9rrIIAd4130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452572.RAn1M-PmcmEXGAyStV5E4gWs-zoGNZq0SHHpf9rrIIAd4130_provenance.
• NP452574.RAhue0yVKsLXhg_uTYwsqKFDCw-V5FTLsv23uvCw9l7Ik130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452574.RAhue0yVKsLXhg_uTYwsqKFDCw-V5FTLsv23uvCw9l7Ik130_provenance.
• NP452575.RArcS1a4SxYiWbrJ12DuWFDCQUOAKm7qLH8vlzeuq1410130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452575.RArcS1a4SxYiWbrJ12DuWFDCQUOAKm7qLH8vlzeuq1410130_provenance.
• NP452581.RAtFnUF_qOVqhYx_dBGHrqTz90NEEz2I7QPvpC1KETJOc130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452581.RAtFnUF_qOVqhYx_dBGHrqTz90NEEz2I7QPvpC1KETJOc130_provenance.
• NP318213.RAExCGIq1LgRmDj-7rMlKpcxmIV5_rkXlO00CC6AFllcc130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318213.RAExCGIq1LgRmDj-7rMlKpcxmIV5_rkXlO00CC6AFllcc130_provenance.
• NP869312.RAIo3DRafKOO-7kYEzpDl2N95CHXGaSRVKNsQq-vJrxmA130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869312.RAIo3DRafKOO-7kYEzpDl2N95CHXGaSRVKNsQq-vJrxmA130_provenance.
• NP452569.RAGLM08MVVH0gSu95LZJEfp5pkstYENvIEdixxT8Bef0w130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452569.RAGLM08MVVH0gSu95LZJEfp5pkstYENvIEdixxT8Bef0w130_provenance.
• NP452576.RA7i0qyYk5Ax6YYloirD85k1L9IapClxsA-ZhcoOS6KZA130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452576.RA7i0qyYk5Ax6YYloirD85k1L9IapClxsA-ZhcoOS6KZA130_provenance.
• NP452578.RAyd5Cyj_Hd2zK_xO-afPXPDPS56tAypZS9Vkku5C83gk130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452578.RAyd5Cyj_Hd2zK_xO-afPXPDPS56tAypZS9Vkku5C83gk130_provenance.
• NP452579.RA-Ibs2vHgt5dkhqMVltOjWGbXoRDCbZKLDXRXtlua95o130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452579.RA-Ibs2vHgt5dkhqMVltOjWGbXoRDCbZKLDXRXtlua95o130_provenance.
• NP932472.RA3TDJXvBH_8HQeBWazncv3CQEY533DVwAH4EU6pqeWpM130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932472.RA3TDJXvBH_8HQeBWazncv3CQEY533DVwAH4EU6pqeWpM130_provenance.